Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

733
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
733
Drug Therapy01:28

Drug Therapy

361
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
361
Behavior Therapy01:22

Behavior Therapy

873
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
873
Traumatic Memory01:20

Traumatic Memory

654
Emotionally traumatic events often lead to memories that are exceptionally vivid and enduring, sometimes persisting with remarkable clarity throughout an individual's life. A classic example of this phenomenon is a person who survives a car accident. Even years later, they may recall every detail of the event with startling accuracy — the screeching of the tires, the jarring impact, and the acrid smell of burning rubber. Such vividness contrasts sharply with how an individual...
654
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

871
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
871
Introduction to Stress and Lifestyle01:27

Introduction to Stress and Lifestyle

740
Stress is a multifaceted response to events perceived as challenging or threatening, highlighting physical, emotional, cognitive, and behavioral reactions. Physically, stress can lead to fatigue, sleep disruptions, and various health issues such as frequent colds, chest pains, and nausea. Emotionally, it can manifest as anxiety, depression, irritability, and anger triggered by both minor and major life events. Cognitively, it may result in difficulty in concentration, memory, and...
740

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping DNA Methylation Signatures to Identify Epigenetic Variation Across Subcortical Regions of the Human Posttraumatic Stress Disorder Brain.

Biological psychiatry·2025
Same author

Single-cell transcriptomic and chromatin dynamics of the human brain in PTSD.

Nature·2025
Same author

A multi-omic approach implicates novel protein dysregulation in post-traumatic stress disorder.

Genome medicine·2025
Same author

Posttraumatic Stress Disorder and Type 2 Diabetes Outcomes in Veterans.

JAMA network open·2024
Same author

The PTSD Criterion A debate: A brief history, current status, and recommendations for moving forward.

Journal of traumatic stress·2023
Same author

An empirical investigation of definitions of subthreshold posttraumatic stress disorder.

Journal of traumatic stress·2023
Same journal

Dynorphinergic neuroadaptations in the islands of Calleja: implications for alcohol use disorder.

Neuroscience letters·2026
Same journal

Differential vulnerability of cochlear nuclei to Lmx1 deficiency: abnormal patterning and implications for auditory circuitry.

Neuroscience letters·2026
Same journal

Role of nNOS/sGC pathway in the insular cortex in control of cardiovascular, autonomic and corticosterone responses to restraint stress in rats.

Neuroscience letters·2026
Same journal

Jak1 inhibition reduces acute allodynia induced by specific upstream cytokines in rats: implications for the onset of Jak1 pain modulation.

Neuroscience letters·2026
Same journal

Glucocorticoids-induced depressive-like behaviors in mice: oral ingestion of corticosterone or hydrocortisone - A comparative study.

Neuroscience letters·2026
Same journal

Data-driven clustering of prefrontal activation identifies functional phenotypes under prioritized dual-task walking conditions in Parkinson's disease.

Neuroscience letters·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.6K

Considering future pharmacotherapy for PTSD.

Matthew J Friedman1, Nancy C Bernardy1

  • 1National Center for Posttraumatic Stress Disorder (116D), Veterans Affairs Medical Center, 215 North Main Street, White River Junction, VT 05009, USA; Geisel School of Medicine at Dartmouth, Department of Psychiatry, 1 Rope Ferry Road, Hanover, NH 03755, USA.

Neuroscience Letters
|November 29, 2016
PubMed
Summary
This summary is machine-generated.

Developing new medications for posttraumatic stress disorder (PTSD) is slow. Research is exploring PTSD pathophysiology and biomarkers to create more targeted and effective pharmacological treatments.

Keywords:
AugmentationGenomicPharmacotherapyPhenotypePosttraumatic stress disorderRandomized clinical trials

More Related Videos

Author Spotlight: Unveiling Mechanisms of Stress Resilience - Significant Findings, Advancements, and Future Research
05:03

Author Spotlight: Unveiling Mechanisms of Stress Resilience - Significant Findings, Advancements, and Future Research

Published on: December 15, 2023

5.1K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.9K

Related Experiment Videos

Last Updated: Mar 11, 2026

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.6K
Author Spotlight: Unveiling Mechanisms of Stress Resilience - Significant Findings, Advancements, and Future Research
05:03

Author Spotlight: Unveiling Mechanisms of Stress Resilience - Significant Findings, Advancements, and Future Research

Published on: December 15, 2023

5.1K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Posttraumatic stress disorder (PTSD) is a widespread and chronic condition with significant societal and economic impacts.
  • Current pharmacological treatments for PTSD are limited, often repurposed from other conditions, and lack recent advancements in randomized clinical trials.
  • Understanding PTSD's complex pathophysiology is crucial for developing novel therapeutic targets.

Purpose of the Study:

  • To review the current state of pharmacological treatments for PTSD.
  • To explore the challenges in identifying effective therapeutic targets for PTSD.
  • To highlight emerging research directions and future strategies for PTSD pharmacotherapy.

Main Methods:

  • Review of existing literature on PTSD pharmacotherapy and pathophysiology.
  • Analysis of recent randomized clinical trials (RCTs) for PTSD medications.
  • Discussion of neurobiological systems implicated in PTSD, including neurotransmitter and neuroendocrine pathways.

Main Results:

  • Despite extensive research, few novel pharmacotherapies for PTSD have been developed recently.
  • Numerous neurobiological systems (adrenergic, monoaminergic, glutamatergic, etc.) are implicated in PTSD pathophysiology, presenting complex targets.
  • Biomarker research shows promise for identifying distinct PTSD clinical phenotypes and guiding personalized treatment strategies.

Conclusions:

  • Advancing PTSD pharmacotherapy requires a deeper understanding of its underlying pathophysiology.
  • Future research should focus on novel targets and biomarker-driven approaches for more specific and effective treatments.
  • Developing targeted pharmacological interventions is essential to address the unmet needs in PTSD treatment.